Influence of Simvastatin and Interleukin 1 Receptor Antagonist on Expression of Aryl Hydrocarbon Receptors Under Experimental Acute Ileitis
Aryl hydrocarbon receptor (AhR) — transcription factor activated by a large number of environmental agents, and may play a role in the pathogenesis of inflammatory bowel diseases in humans and mouse models. We have investigated the possibility of using simvastatin and interleukin 1 receptor antagonist for pharmacological correction of acute ileitis in rats, with a focus on the studying intensity of AhR expression by lymphocytes of the small intestine. The AhR-immunopositive lymphocytes were determined by means of indirect immunofluorescence technique using monoclonal rat antibodies. We have established that development of ileitis was associated with changes in the amount of AhR+ lymphocytes and their density on immunopositive cells. Drug administration during the development of experimental pathology was accompanied by changes in the expression of AhR and their density on lymphocytes.
Full Text:PDF (Українська)
Zelante T. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22 / T. Zelante, R.G. Iannitti, C. Cunha [et al.] // Immunity. — 2013. — Vol. 39. — Р. 372-385.
Apetoh L. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27 / L. Apetoh, F.J. Quintana, C. Pot [et al.] // Nat. Immunol. — 2010. — Vol. 11(9). — Р. 854-861.
Veldhoen M. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins / M. Veldhoen, K. Hirota, A.M. Westendorf [et al.] // Nature. — 2008. — Vol. 453(7191). — Р. 106-109.
Platzer B. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells / B. Platzer, S. Richter, D. Kneidinger [et al.] // J. Immunol. — 2009. — Vol. 183(1). — Р. 66-74.
Kiss E.A. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles / E.A. Kiss, C. Vonarbourg, S. Kopfmann [et al.] // Science. — 2011. — Vol. 334(6062). — Р. 1561-1565.
Jain M.K. Anti-inflammatory effects of statins:clinical evidence and basic mechanisms / M.K. Jain, P.M. Ridker // Nat. Rev. Drug Discov. — 2005. — Vol. 4(12). — Р. 977-987.
Hackam D.G. Statins andsepsis in patients with cardiovascular disease: a population-based cohort analysis / D.G. Hackam, M. Mamdani, P. Li [et al.] // Lancet. — 2006. — Vol. 367(9508). — Р. 413-418.
Nandi J. TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis / J. Nandi, B. Saud, J. Zinkievich [et al.] // Mol. Cell. Biochem. — 2010. — Vol. 336(1–2). — P. 17-24.
Yamada T. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin / T. Yamada, E. Deitch, R.D. Specian [et al.] // Inflammation. — 1993. — Vol. 17(6). — P. 641-662.
Monteleone I. The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis / I. Monteleone, T.T. MacDonald, F. Pallone [et al.] // Curr. Opin. Gastroenterol. — 2012. — Vol. 28(4). — P. 310-313.
Furumatsu K. A role of the aryl hydrocarbon receptor in attenuation of colitis / K. Furumatsu, S. Nishiumi, Y. Kawano [et al.] // Dig. Dis. Sci. — 2011. — Vol. 56(9). — P. 2532-2544.
Takamura T. Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice / T. Takamura, D. Harama, S. Matsuoka [et al.] // Immunol. Cell. Biol. — 2010. — Vol. 88(6). — P. 685-689.
Veldhoen M. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins / M. Veldhoen, K. Hirota, A.M. Westendorf [et al.] // Nature. — 2008. — Vol. 453(7191). — P. 106-109.
- There are currently no refbacks.
Copyright (c) 2016 GASTROENTEROLOGY
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2018